Home Products Most Popular Contact
No items in your cart.
The page below is a sample from the LabCE course HIV Safety for Florida Clinical Laboratory Personnel. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about HIV Safety for Florida Clinical Laboratory Personnel (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 111 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Florida HIV Safety, Medical Errors & Laws and Rules$40 Add to cart
Histology CE Package$65 Add to cart
Phlebotomy CE Package$45 Add to cart
Individual course$20 Add to cart

Postexposure Prophlaxis (PEP)

PEP is recommended when occupation exposure to HIV occurs. The U.S. Public Health Service provides the following guidelines:
  • If possible, determine the HIV status of the source patient to guide need for HIV PEP
  • Start PEP medication regimens as soon as possible after occupational exposure to HIV and continue them for four weeks.
    • PEP medication regimens should contain at least three antiretroviral durgs for all occupational exposures to HIV.
  • Expert consultation is recommended for any occupational exposures to HIV
  • Provide close follow-up for exposed personnel that includes counseling, baseline and follow-up HIV testing, and monitoring for drup toxicity. Follow-up appointments should begin within 72 hours of an HIV exposure.
  • If a newer 4th generation combination HIV p24 antigen-HIV antibody test is utilized for follow-up HIV testing of exposed healthcare personnel, HIV testing may be concluded at 4 months after exposure. If a newer testing platform is not available, follow-up HIV testing is typically concluded at 6 months after an HIV exposure.


Reference: Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Available at: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0. Accessed September 28, 2018.